34 results about "Cardiopulmonary disease" patented technology

The invention relates to slowly digestible starch-containing foodstuffs, such as cereals and snacks, while a substantial percentage of the starch phase of starch-containing foodstuffs is transformed into a slowly digestible form in situ during foodstuff manufacture by modifying the method typical for the respective foodstuff, and if necessary, the recipe. During the manufacture of starch-containing foodstuffs, the starch is most often prepared to the extent where it digested exceedingly quickly, and converted into glucose in the process. This leads to a rapid rise in the blood sugar level (high sugar), followed by a speedy to severe drop in the blood sugar level (low sugar). These foodstuffs have a high glycemic index (GI). A high number of more recent studies suggest that foodstuffs with a high GI are a significant cause of diabetes, obesity and cardiopulmonary diseases. The WHO believes that indicating GI values on foodstuff packaging would effectively help in preventing the mentioned diseases. Therefore, there is a need for starch-containing foodstuffs that have a reduced GI, i.e., are slowly digested. Within this context, the ideal scenario involves a foodstuff with a constant hydrolysis over time, wherein precisely the amount of glucose consumed for metabolism is released per unit of time. Such a foodstuff would be exceedingly desirable in particular for diabetics. The best currently existing solution for diabetics in this regard is uncooked, i.e., native corn starch (WO 95 / 24906), which is digested relatively slowly. However, the consumption of native cornstarch in the form of an aqueous slurry is unattractive on the one hand, and only a limited time-constant release of glucose can here be achieved on the other. In addition, the temperature stability of native cornstarch is limited, so that only very limited incorporation in processable foodstuff preparations is possible. Other forms of slowly digestible starches include resistant starches (e.g., high corn, Novelose, ActiStar, CrystaLean). These starches exhibit a high crystalline percentage, and about 50% can be digested in the small intestine. The remainder is fermented in the large intestine. The percentage that can be digested in the small intestine is predominantly digested very quickly, so that it makes sense to use only a limited amount of resistant starches as food additives for reducing the GI. Other slowly digestible starches are described in WO 2004 / 066955 A2. These starches are obtained by gelatinizing a suspension of about 5% starch in water,

The present invention is one kind of the recipe and preparation process of cardiopulmonary disease treating Chinese medicine composition. The Chinese medicine composition includes main material comprising astragalus root, pepperweed seed, Chuanxiong rhizome and trichosanthes peel, as well as supplementary material. The Chinese medicine composition as one kind of Chinese medicine injection for treating cardiopulmonary disease is superior to available medicines in that it can obviously lower CO2 partial pressure and raise oxygen partial pressure.

A treatment apparatus including: a bronchoscope including a flexible shaft having working channel; a transbronchial ablation probe configured to extend from a distal end of the working channel and extend thru a wall of a trachea and into tissue outside of the trachea; and a stabilization element mounted to a distal portion of the flexible shaft, wherein the stabilization element is configured to brace the distal portion against the wall of the trachea while the transbronchial ablation probe is extended through the wall of the trachea.

A medical herb composition for the alleviation of cardiopulmonary ailments or the improvement of cardiopulmonary function in a mammal is disclosed. The medical herb composition comprises: Schisandra extract; Ginseng extract; Radix ophiopogonis extract; and Saliva miltiorrhiza extract. The medical herb composition comprising the extracts above is proved to be efficient in enhancing cardiopulmonary function of a mammalian patient without heart disease, enforcing energy and raising strength. The medical herb composition is also capable of reducing the symptoms of breathing difficulties and stagnation of vital energy.

In certain embodiments, methods of the present invention obtain NMR spectroscopy signal data that corresponds to the behavior of the polarized 129Xe at a selected site(s) in selected environments in vivo. The gas exchange signal data can be used to evaluate: (a) the thickness of a barrier, such as a membrane, lining, wall or width of a lumen; (b) the operational condition or function of a membrane, body system or portion thereof; (c) cerebral perfusion; and / or (c) the efficacy of a therapeutic treatment used to treat a diagnosed disorder, disease, or condition. Thus, the present invention provides methods for screening and / or diagnosing a disorder or disease, and / or methods for monitoring the efficacy of therapeutics administered to subject to treat a disorder or disease.

In certain embodiments, methods of the present invention obtain NMR spectroscopy signal data that corresponds to the behavior of the polarized 129Xe at a selected site(s) in selected environments in vivo. The gas exchange signal data can be used to evaluate: (a) the thickness of a barrier, such as a membrane, lining, wall or width of a lumen; (b) the operational condition or function of a membrane, body system or portion thereof; (c) cerebral perfusion; and / or (c) the efficacy of a therapeutic treatment used to treat a diagnosed disorder, disease, or condition. Thus, the present invention provides methods for screening and / or diagnosing a disorder or disease, and / or methods for monitoring the efficacy of therapeutics administered to subject to treat a disorder or disease.

The invention discloses equipment, a system and a method for testing a cardiac motion function. Series of indexes of cardiac strain capacity are proposed, the capacity of cardiac rate adaptively changing with motion change and the strain velocity are quantitatively described, and the whole dynamic process of the heart in a metabolic process of a human body is described. The invention discloses the equipment adopting a wearable intellisense technology to measure the series of indexes of the cardiac strain capacity in real time as well as CET. Compared with CPX (cardiopulmonary exercise testing) and parameters such as maximal oxygen uptake and the like measured with CPX, the series of indexes of the cardiac strain capacity have clear clinical significance and definite normal reference value; CET is simple and convenient to implement and can be implemented anytime and anywhere, and the test risk is greatly reduced. The equipment, the system and method have great significance and application prospect for popularization of cardiopulmonary disease prevention and rehabilitation.

The invention discloses Chinese medicinal powder for treating an ischemic heart disease, which is prepared from six Chinese medicinal materials: American ginseng, root of red-rooted salvia, notoginseng root, dwarf lilyturf tuber, Chinese angelica and shizandra berry. In the Chinese medicinal powder has a formula of medicines, and is scientific and reasonable in compatibility; and the Chinese medicinal powder achieves the effects of nourishing heart, nourishing blood, promoting blood circulation and invigorating yang to consolidate constitution by nourishing heart and blood, invigorating yang to consolidate constitution and strengthening body resistance under the combined and synergistic action of the medicines, so the Chinese medicinal powder is particularly suitable for treating the ischemic heart disease and also has the obvious curative effect on other heart diseases, pulmonary heart diseases and emphysema. By the Chinese medicinal powder, the problem that the medicines for treating the ischemic heart disease have large side effect and the problem that coronary heart diseases and other heart and pulmonary diseases cannot be treated by one medicine but must be treated under the combined action of the medicines are solved; and various heart diseases caused by myocardial ischemia can be cured fundamentally to solve the problem that the ischemic heart disease is relapsed repeatedly after the treatment of the conventional medicine for treating the ischemic heart disease, and one medicine with multiple medicinal effects also relieves economic burdens for patients.

Methods and devices for treating patients having cardiopulmonary disease such as cardiac arrhythmias, ventricular arrhythmias, pulmonary hypertension, or heart failure comprising a tracheal approach. The method includes ablating a deep cardiac plexus of a patient by advancing an treatment apparatus into a trachea of the patient, extending an ablative energy delivery element of the treatment apparatus through a wall of the trachea at a level of the trachea proximate a tracheal bifurcation, positioning the ablative energy delivery element at a target space between the trachea, an aorta and a pulmonary artery, and ablating, by the ablative energy delivery element, tissue within the target space to substantially disable the deep cardiac plexus.

A treatment apparatus (200) including: an elongated airway device (112, 218); and a transbronchial ablation probe (120, 220) extendable from the distal portion of the airway device. A method of treating heart disease by ablating a portion of the cardiac plexus is provided.

The invention discloses a wearable device for cardiopulmonary rehabilitation training. The training intensity adjustment elastic member of the present invention can adjust the intensity of cardiac rehabilitation training and the breathing gas flow rate of pulmonary rehabilitation training. Monitor the situation, and automatically adjust the training intensity adjustment elastic parts, so that the corresponding intensity of training can be carried out in a state suitable for the patient's own body, so that the patient can automatically adjust the required training intensity according to his own situation when using it, and ensure the curative effect of the patient's rehabilitation training ; During rehabilitation training, the present invention monitors the patient's health status in real time, reduces the risk of adverse events during patient training, and thus improves the safety of rehabilitation training for patients with cardiopulmonary diseases.

The invention discloses an intelligent breathing training device and a monitoring method thereof. The intelligent breathing training device comprises an expiration damper drive plate, a connecting transverse pipe, a transition bottle, a first-stage gas cylinder, a second-stage gas cylinder, a third-stage gas cylinder, a base, an inspiration damper drive plate, a corrugated pipe, a digital counterand a horn-shaped breathing opening, and the transition bottle is communicated with the connecting transverse pipe through a transition bottle connecting vertical pipe; the transition bottle and the base are screwed together through the inspiration damper drive plate. The transition bottle, the first-stage gas cylinder, the second-stage gas cylinder and the third-stage gas cylinder are communicated with the connecting transverse pipe and are all fixedly placed on the base; the corrugated pipe is fixedly connected with one end of the digital counter, and the horn-shaped breathing opening is inserted into the other end of the digital counter. By using the device, scientific respiratory training is carried out through accurate counting of the digital counter, and the purposes of efficient training and effective treatment of cardiopulmonary diseases can be achieved.

An ECMO skill training simulation teaching system comprises simulated ECMO equipment, a simulated ECMO pipeline, a simulated monitoring system, a simulated human body model, an ultrasound-guided artery-vein puncture module, an artery and vein blood circulation device, a respiratory movement simulation device, a plurality of electrocardiogram simulation devices, a plurality of cardiopulmonary palpation auscultation simulation devices and an arterial blood pressure measurement simulation device. A simulated console, a simulated air-oxygen mixer, a simulated oxygenator, a simulated centrifugal pump and a variable-temperature water tank are arranged. A power control box is arranged. The simulation human body model is provided with a right carotid artery, an internal jugular vein, bilateral femoral arteries, veins and an ultrasound-guided puncture module. A pump box is provided with an artery and vein circulation device. Vivid critical scenes of various cardiopulmonary diseases can be set by simulating respiratory movement, electrocardiogram monitoring, cardiopulmonary touch auscultation and blood pressure measurement. The system can be connected with simulated ECMO or real ECMO equipment for training and examination such as pipeline pre-flushing, artery and vein puncture catheterization and monitoring, the whole ECMO skill training process is achieved, the simulation effect is highly simulated, and the training effect is remarkably improved.

The invention discloses a positioning alarm medical wrist strap capable of preventing a patient from getting lost. The positioning alarm medical wrist strap comprises a shell, wherein the front surface of the shell is fixedly connected with a display screen; the bottom of the front surface of the shell is fixedly connected with a positioning module; the bottom of the shell is fixedly connected with a first connecting band; a fixing hole is formed in the front surface of the first connecting band; the top of the shell is fixedly connected with a second connecting band; a wrist strap buckle is mounted at one end, which is far away from the shell, of the second connecting band; a temperature detection probe and a heart rate detection probe are respectively mounted on the back surface of the shell from top to bottom; and a button is arranged on the right side of the shell. The problems that an existing medical wrist strap does not have a positioning alarm function, family members or nurses are far away from the sight of the family members or nurses by accident in the hospitalization period and are inconvenient to find, great potential safety hazards are caused to the patient, meanwhile, the heart rate and the temperature of the patient cannot be monitored in real time, and the using effect is poor particularly for patients suffering from cardiopulmonary diseases are solved.

The invention discloses a medical care structure for treating a cardiopulmonary disease. The medical care structure comprises a telescopic airbag, the two ends of the telescopic airbag are connected with a first end cover and a second end cover, a plurality of one-way air inlet holes and one-way communicating valves are arranged on the surfaces of the two end covers correspondingly, air outlets ofthe one-way communicating valves are connected with a three-way connector through an air guiding hose, the three-way connector is connected with an agentia storage tank in a communicating mode, and an outlet of the agentia storage tank is connected with a nasal cavity plug in a communicating mode; and the telescopic airbag is compressed or pulled, in the pulling process, external air enters an inner cavity of the telescopic airbag through the one-way air inlet holes to be compressed, the compressed air reaches the three-way connector through the one-way communicating valves, meanwhile, a setdose of drug for treating the cardiopulmonary disease is released from the agentia storage tank, the drug joins with the air in the three-way connector, and then enters the respiratory tract of a patient from the nasal cavity plug under the pressure of the compressed air to treat the disease, and thus good practical value is achieved.

Methods and systems estimate cardio-respiratory parameter(s), such as from in-phase and quadrature channels. The channels may represent patient chest movement and may be generated with a sensor, such as a contactless sensor that may sense movement with radio-frequency signals. In the methods / systems, the in-phase and quadrature channels may be processed, such as in a processor(s), using relative demodulation to generate cardio-respiratory parameter estimate(s). Optionally, the processing produces a jerk signal that may be filtered for producing a heart rate estimate, such as from zero-crossings of the filtered signal. Optionally, the processing produces a chest velocity signal that may be filtered for producing a respiratory rate estimate, such as from zero-crossings of the filtered signal. Optionally, a respiratory volume, such as tidal volume, may be estimated from an intrapulmonary pressure signal generated by applying a function to a chest displacement signal where the function relates intrapulmonary pressure and chest displacement.

The invention discloses a traditional Chinese medicine mask for bacteriostasis and antibiosis. The mask comprises a mask body and hanging lugs, the hanging lugs are fixedly installed on the two sidesof the mask body, a medicine storage interlayer is arranged on the side, close to the face, of the mask body, a traditional Chinese medicine bag is arranged in the medicine storage interlayer, the mask body is sequentially provided with a mask outer surface layer, a first fiber non-woven fabric layer, a melt-blown cotton layer, a far infrared emission layer and a second fiber non-woven fabric layer from outside to inside, and the lower surface of the mask outer surface layer is fixedly adhered to the upper surface of the first fiber non-woven fabric layer. The traditional Chinese medicine bagis arranged on the mask body, folium artemisiae argyi, cyrtomium fortunei, rhizoma atractylodis and radix angelicae are added into the traditional Chinese medicine bag, the folium artemisiae argyi hasfunctions of resisting bacteria and enhancing reticuloendothelial cell phagocytizing, the radix angelicae has an obvious antibacterial effect, the cyrtomium fortunei has the effects of clearing awayheat and toxic materials, and the rhizoma atractylodis has the effects of drying dampness, tonifying spleen, expelling wind and removing cold. Various traditional Chinese medicinal materials are matched for use, so that bacteriostatic and antibacterial effects on respiratory tract and cardiopulmonary functions are achieved, and cardiopulmonary diseases can be effectively prevented.

The invention relates to the field of medical care, and discloses a mask capable of preventing apnea. The mask comprises a mask body, a mask cavity is formed in one side of the mask body, one wall of the mask cavity is fixedly connected with a breathing tube, a breathing pipeline is arranged in the breathing tube in a penetrating mode, one side of the breathing pipeline communicates with a connecting channel, the lower side of the connecting channel communicates with an air cavity, the two sides of the mask cavity are jointly and fixedly connected with a fixing band, one side of the outer circle of the fixing band is fixedly connected with a limiting band, and one side of the mask cavity is provided with a breathing assembly communicating with the air cavity. According to the mask capable of preventing apnea, the mouth is fixed through an elastic band, the situation that a user breathes through the mouth in the sleep period and consequently the health of the user is affected is prevented in the mode that the mouth is opened in the sleep period, meanwhile the breathing state of the user can be detected in the sleep period of the user, when breathing goes wrong, the breathing assisting function can be started to assist the user in breathing, and cardiopulmonary diseases can be prevented.

The present disclosure provides, inter alia, methods for treating or ameliorating the effect of a cardiopulmonary disease, including right ventricular failure (RVF), in a subject. Also provided are methods for diagnosing the risk of having RVF in a subject, methods for preventing RVF in a subject, methods for preventing non-canonical autophagy, methods for mitigating oxidative stress in mitochondria of a cell, and methods for inhibiting microtubule-mediated active mRNA transfer in a cell. A pharmaceutical composition and treatment methods using such composition are also provided.

An intelligent and real-time cardio-pulmonary screening device (100) is disclosed. The device comprises a housing that encloses a body, said body comprising: a display unit (101); a plurality of light emitting diode (LED) indicators (102, 103); a first toggle switch (104); a second toggle switch (105); a plurality of volume controls (106, 107); a third toggle switch; an output port (109); a switch (110); a charging port (111); a temperature sensor; a transducer unit (112); and an artificial intelligence module. The artificial intelligence module analyses the sounds received in real-time and presents the results in the display unit (101), as well as in the plurality of the LED indicators (102, 103); it comprises an artificial intelligence processor that is configured to run machine learning algorithms on the device (100), with said artificial intelligence module syncing from and to the cloud when connected to internet. The disclosed device (100) is an easy to use, affordable, point of care screening device that classifies underlying cardio-pulmonary diseases within a minute.

The invention provides a CPG (Central Pattern Generator)-based cardiopulmonary rhythm synchronous control experimental platform. The CPG-based cardiopulmonary rhythm synchronous control experimental platform comprises two parts, namely an FPGA (Field Programmable Gate Array) development board and an upper computer, wherein the two parts are mutually connected through a USB (Universal Serial Bus) interface; the FPGA development board is used for realizing a cardiac muscle cell network model, a CPG model and an FFT (Fast Fourier Transform) algorithm; the upper computer is used for designing an upper computer software interface by adopting LabVIEW and is in communication with the FPGA development board. The CPG-based cardiopulmonary rhythm synchronous control experimental platform provided by the invention has the effects that through an FPGA neural network experimental platform based on high-speed computation which is used for carrying out non-animal testing on biological neural networks, regulation and control of a CPG on cardiopulmonary rhythm synchronization are realized, and the time-scale consistency with real biological neurons can be ensured; according to the CPG-based cardiopulmonary rhythm synchronous control experimental platform, a visual research platform which is more approximate to a real neural network is provided for researching a mechanism and control of the cardiopulmonary rhythm synchronization, and the CPG-based cardiopulmonary rhythm synchronous control experimental platform has the important practical value in researching and treating multiple cardiopulmonary diseases comprising a cardiovascular disease and the like.

The invention relates to the field of medicines, and particularly discloses a traditional Chinese medicine composition, a preparation method thereof, a black plaster and application. The traditional Chinese medicine composition comprises the following raw materials: radix salviae miltiorrhizae, rhizoma chuanxiong, radix aconiti carmichaeli, rhizoma zingiberis, cortex cinnamomi, edible vegetable oil and yellow lead. The traditional Chinese medicine composition provided by the invention can be used for treating heart diseases, is an external medicine, and does not need to be orally taken, so that the medication safety is improved; through cooperative use of multiple raw materials, the traditional Chinese medicine composition has effects of effectively preventing invasion of external wind-cold dampness and discharging wind-cold dampness in a heart region, so that recovery and health of heart functions are greatly improved; furthermore, the preparation method is simple, the auxiliary treatment effect for heart and lung diseases is obvious, recovery of the diseases is accelerated, the traditional Chinese medicine composition is convenient to use and good in effect, a new way is added for a treatment method of the heart and lung diseases, and the problem that the medication safety is influenced due to the fact that most of the existing medicines for treating the heart diseases are orally taken and have toxic and side effects is solved.

Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases or disorders are provided. In accordance with the instant invention, methods of inhibiting, treating, and / or preventing peripheral artery disease or symptoms associated therewith are provided. In a particular embodiment, the methods inhibit, treat, and / or prevent claudication associated with peripheral artery disease.

The present invention provides compounds effective as sphingosine-1-phosphate receptor modulators for the treatment of cardiopulmonary disorders such as hypertension (including malignant hypertension), angina, myocardial infarction, arrhythmia , congestive heart failure, coronary heart disease, atherosclerosis, angina, dysrhythmia, cardiomyopathy (including hypertensive cardiomyopathy), heart failure, cardiac arrest, bronchitis, asthma, chronic obstructive pulmonary disease, cystic fibrosis , croup, emphysema, pleurisy, pulmonary fibrosis, pneumonia, pulmonary embolism, pulmonary hypertension, mesothelioma, ventricular conduction abnormalities, complete cardiac obstruction, adult respiratory distress syndrome, sepsis syndrome, idiopathic pulmonary Fibrosis, scleroderma, systemic sclerosis, retroperitoneal fibrosis, prevention of keloid formation, or cirrhosis.

The invention relates to the technical field of traditional Chinese medicines, and in particular to a traditional Chinese medicinal composition for treating cardiopulmonary diseases through external application. The composition consists of 20-30g of peach kernels, 20-40g of semen ginkgo, 20-50g of fructus gardeniae, 20-30g of rhizoma coptidis, 6-15g of flos carthami, 30-50g of radix salviae miltiorrhizae, 30-50g of fructus trichosanthis, 20 pieces of fructus piperis alba, 30-50g of semen momordicae, 30-50g of black semen pharbitidis and 30-50g of white semen pharbitidis. The traditional Chinese medicinal composition provided by the invention not only can radically treat the cardiopulmonary disease but also can comprehensively condition various organs of human body; and especially, the traditional Chinese medicinal composition can take the best curative effect on infantile congenital incomplete heart, pores and the like of cardiopulmonary and bronchial diseases.

The invention relates to a wearable breathing device, comprising: a mask body, a filter module and a breathing module. The mask body has a first installation through hole and a second installation through hole. The filter module and the breathing module are respectively installed in the first installation through hole and the second installation through hole, and the breathing module includes an exhalation unit or an air supply unit. The exhalation unit or the air supply unit can be detachably installed in the same installation through hole, and can be replaced according to the selection of different breathing modes. The selection of different breathing modes enables the wearable breathing device to solve the problems that the traditional wearable breathing device is suitable for a limited number of people and uses a single method. Healthy people or people who exercise too little can choose the self-priming type when using the wearable breathing device, and the elderly, children or patients with cardiopulmonary diseases can choose the air-supplied type when using the wearable breathing device.